Stichting Martini Ziekenhuis — Clinical Trial Site

66 Registered trials

26 Currently recruiting

Organisation

Stichting Martini Ziekenhuis

Location

Groningen, Netherlands

Identifier

ORG-100024569

Address

Van Swietenplein 1, 9728 NT, Netherlands

Departments

#3716: Cardiology
2607:Cardiology
3716: Cardiology
Afd. Longziekten
Brandwondencentrum
Brandwondencentrum Groningen
Cardiologie
Cardiology
Cardiology Department
Cardiology research
Department of Internal Medicine
Department of Medical Oncology
Department of Neurology
Department of Pulmonology Diseases
Department of Surgery
Gynaecology
Hematology
ICU
infectious diseases
Intensive Care
Internal medicine
interne geneeskunde
Longziekten
Maag-, darm-, leverziekten
Martini Ziekenhuis( #1)
Medical Oncology
Medische Oncologie
n/a
Oncology
Pediatrics
Pharmacy
Pneumology
Pulmonary diseases and thoracic oncology
Pulmonary Science
Pulmonology
Reproductive medicine and gynecology
Research cardiology
Rheumatology
Sugery
Surgery
Urology
Wetenschappelijk Instituut

Clinical trials at this site (66)

Search interface

A study to investigate long-term safety and tolerability of tolebrutinib in participants with multiple sclerosis Not authorised

2023-503631-18-00 Nervous system diseases 5
Ultrasound-guided Radiofrequency Ablation versus radioactive Iodine as treatment for Hyperthyroidism caused by Solitary Autonomous Thyroid N… Pending

2024-515602-34-01 Hyperactive thyroid nodules 11
A Study to Test How Well ZL-1310 may Work Compared to Therapies Selected by the Investigator in Treating Patients with Relapsed Small Cell L… Pending

2025-522818-23-00 Small Cell Lung Cancer (SCLC) 5
A Randomized, Double-Blind, Phase 3 Study of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treat… Pending

2025-523735-19-00 Metastatic Microsatellite Stable Colorectal Cancer 5
Adjuvant Pembrolizumab in patients with early-stage triple negative breast cancer with residual disease after treatment with chemotherapy an… Pending

2025-524229-41-00 Triple negative breast cancer 5
HO182 CLL: Treatment of patients with chronic lymphocytic leukemia (CLL) with 6 cycles of rituximab in combination with 6 or 26 cycles of ve… Pending

2025-524283-38-00 Relapsed or refractory chronic lymphocytic leukemia 5
Albuminuria Reduction Trial and Investigation with Survodutide Treatment in CKD (ARTIST-CKD) Pending

2025-525068-13-00 Chronic Kidney Disease 4
An open-label extension (OLE) trial to evaluate long-term safety and tolerability of pelacarsen (TQJ230) Recruiting

2024-519870-38-00 Atherosclerotic cardiovascular disease (ASCVD) 5 2026-05-11
Adjuvant chemotherapy for prevention of recurrence in patients with detectable ctDNA after surgery in high-riskrectal cancer. Recruiting

2024-517700-12-00 Rectal cancer 5 2025-12-10
The Intensive Care Platform Trial (INCEPT) Recruiting

2024-516208-41-00 Acute critical illness requiring intensive care unit ad 6 2025-06-26
A multicentre, intra-patient randomised controlled Phase III study to confirm the efficacy and safety of denovoSkin™, a bilayer engineered c… Recruiting

2023-507717-94-00 Deep partial and full-thickness burns 5 2024-12-06
Dual-Wavelength Quantitative Fluorescence Endoscopy for Optical PD-1 and PD-L1 Imaging in Locally Advanced Esophageal Cancer: A Phase I Mult… Recruiting

2024-520090-12-00 Esophageal cancer 1 2026-05-01
Pasritamig vs Placebo in late line Metastatic Castration-resistant Prostate Cancer (mCRPC) Recruiting

2025-520927-26-00 Metastatic Castration-resistant Prostate Cancer (mCRPC) 5 2025-11-24
Clinical Randomised Phase 2 Trial of AP31969 versus Placebo for Rhythm Control of Atrial Fibrillation. Recruiting

2025-521377-14-00 Atrial fibrillation 4 2025-10-06
A clinical study of sacituzumab tirumotecan with or without pembrolizumab in people with breast cancer (MK-2870-011) Recruiting

2024-516834-36-00 Locally recurrent unresectable or metastatic TNBC with 5 2025-07-08
Phase 3 Study of I-DXd Versus Docetaxel in mCRPC Recruiting

2024-517423-40-00 Metastatic Castration-Resistant Prostate Cancer 5 2025-06-23
Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Subjects With Metastatic Colorectal Ca… Recruiting

2022-502352-31-00 Colorectal Cancer (CRC) 5 2025-02-10
Positron emission tomography with macrophage targeting to select individuals at risk for rheumatoid arthritis. Recruiting

2024-513538-40-02 ACPA positive arthralgia 4 2024-12-09
The PREDMETH trial: Effectiveness of methotrexate versus prednisone as first-line therapy for pulmonary sarcoidosis – A randomized controlle… Recruiting

2024-514055-15-00 Pulmonary sarcoidosis 6 2024-11-19
Can we Save the rectum by watchful waiting or transanal surgery following short- or long-course radioTherapy and Additional local oR systemi… Recruiting

2024-514620-17-00 Patients with early-stage rectal cancer (defined as ear 4 2024-10-14
Clinical trial comparing MK-2870 given with pembrolizumab to pembrolizumab alone in participants who have had surgery for NSCLC Recruiting

2023-508012-35-00 Newly diagnosed NSCLC with resectable clinical Stage II 5 2024-10-02
HOVON 170 DLBCL: ANTICIPATE: Prevention of ANThracycline-Induced Cardiac dysfunction by dexrazoxane In PATients with diffusE large B-cell ly… Recruiting

2023-505377-32-00 Diffuse large B-cell lymphoma (DLBCL) 5 2024-08-15
CLEAR-PATH trial Recruiting

2024-513363-15-01 (Chronic) Peripheral (occlusive) arterial disease (PAD) 11 2024-07-22
A Phase 2/3 trial to investigate visualization of the ureters with nizaracianine triflutate, intravenous, in participants aged 18 years or o… Recruiting

2023-503241-63-00 Urinary tract imaging 10 2024-05-21